CervoMed宣佈完成Neflamapimod治療Lewy小體癡呆患者2B階段Rewin

快訊 · 06/11 20:00

CervoMed Announces Completion of Enrollment in Phase 2B Rewind-Lb Clinical Trial of Neflamapimod for the Treatment of Patients With Dementia With Lewy Bodies

CervoMed宣佈完成Neflamapimod治療Lewy小體癡呆患者2B階段Rewind-Lb臨床試驗的招募。